Idhifa has been approved for the treatment of relapsed or refractory acute myeloid leukemia
Acute myeloid leukemia (AML) is an aggressive blood and bone marrow cancer where not all leukemic cells are destroyed...
Acute myeloid leukemia (AML) is an aggressive blood and bone marrow cancer where not all leukemic cells are destroyed...
With increasing incidences of cancer and its recurrence, the scientific community is always trying to invent new remedies and...
Breast cancer is the second leading cause of cancer-related mortality in women, after lung cancer.1 The American Cancer Society...
Ovarian cancer is the 7th most commonly diagnosed cancer in women worldwide1 and the 5th most common cause of...
The US FDA approved the use of Rydapt (midostaurin) in combination with chemotherapy for treating recently diagnosed adults with...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is not breast cancer but a rare type of T-cell lymphoma that...
Skin cancer is common; however, Merkel cell carcinoma (MCC) is a rare type of aggressive skin cancer that affects...
Adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who have responded completely or partially to...
Soft-tissue sarcomas (STS) are an uncommon and diverse group of malignancies originating from mesenchymal precursors that are responsible for...
Human beings are the most evolved organisms on the planet. Many of their tissues can continuously renew throughout life,...